SEER
Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Adaptive Biotechnologies Corp (ADPT)Head of Investor Relations
10x Genomics, Inc. (TXG)Head of Investor Relations
Guardant Health, Inc. (GH)Head of Investor Relations
Pacific Biosciences Of California, Inc. (PACB)Head of Investor Relations
908 Devices Inc. (MASS)Head of Investor Relations
Seer, Inc. (SEER)Head of Investor Relations
Nautilus Biotechnology, Inc. (NAUT)Head of Investor Relations
Ginkgo Bioworks Holdings, Inc. (DNA)Head of Investor Relations
SI-BONE, Inc. (SIBN)Equibles does not estimate personal net worth.
Get an email with a short summary when Adaptive Biotechnologies Corp publishes a filing, an earnings call transcript or a press release.
Get ADPT alertsCarrie Mendivil is recorded as Head of Investor Relations at Adaptive Biotechnologies Corp (ADPT), Head of Investor Relations at 10x Genomics, Inc. (TXG), Head of Investor Relations at Guardant Health, Inc. (GH), Head of Investor Relations at Pacific Biosciences Of California, Inc. (PACB), Head of Investor Relations at 908 Devices Inc. (MASS), Head of Investor Relations at Seer, Inc. (SEER), Head of Investor Relations at Nautilus Biotechnology, Inc. (NAUT), Head of Investor Relations at Ginkgo Bioworks Holdings, Inc. (DNA) and Head of Investor Relations at SI-BONE, Inc. (SIBN). Carrie Mendivil has spoken on 29 earnings calls across 4 companies, most recently for Seer, Inc. on February 27, 2025. Those appearances were for Seer, Inc. (SEER), Guardant Health, Inc. (GH), Nautilus Biotechnology, Inc. (NAUT) and 908 Devices Inc. (MASS). Seer, Inc. is classified in the Biotechnology industry within the Healthcare sector. Guardant Health, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Seer, Inc. includes Omid Farokhzad (CEO and Board Member), Charles Endweiss (CFO and Chief Accounting Officer), Elona Kogan (General Counsel) and 7 others.
“Earlier today, Seer released financial results for the quarter and year ended December 31, 2024.”
“Earlier today, Seer released financial results for the quarter ended September 30, 2024.”
“Earlier today, Seer released financial results for the quarter ended June 30, 2024.”
“Earlier today, Seer released financial results for the quarter ended March 31, 2024.”
“Earlier today, Seer released financial results for the quarter and year ended December 31, 2023.”
SEER
Biotechnology · Healthcare
Head of Investor Relations
Diagnostics & Research · Healthcare
Head of Investor Relations
Biotechnology · Healthcare
Head of Investor Relations
MASS
Medical Devices · Healthcare
Head of Investor Relations
Diagnostics & Research · Healthcare
Head of Investor Relations
Biotechnology · Healthcare
Head of Investor Relations
Medical Devices · Healthcare
Head of Investor Relations